Olivia Newton-John Cancer Wellness and Research Centre

Organization name
Olivia Newton-John Cancer Wellness and Research Centre
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 361-380 of 384 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
361Jun-2017High dose rate brachytherapy source measurement intercomparison.Poder, Joel; Smith, Ryan L; Shelton, Nikki ; Whitaker, May; Butler, Duncan; Haworth, Annette
362Jun-2017Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinomaWhite, Rohen; Foroudi, Farshad ; Sia, Joseph; Marr, Mary Ann; Lim Joon, Daryl 
363Apr-2017Is Mesothelioma in China Rare or Misdiagnosed?John, Thomas ; Russell, Prudence A; Thapa, Bibhusal 
36420-Jan-2017Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?Hawkes, Eliza A ; Chong, Geoffrey ; Grigg, Andrew P 
3652017Prevalence, perceptions and predictors of alcohol consumption and abstinence among South Australian school students: a cross-sectional analysis.Bowden, Jacqueline A; Delfabbro, Paul; Room, Robin; Miller, Caroline L; Wilson, Carlene J 
366Dec-2016Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.Atkinson, Victoria; Long, Georgina V; Menzies, Alexander M; McArthur, Grant; Carlino, Matteo S; Millward, Michael; Roberts-Thomson, Rachel; Brady, Benjamin; Kefford, Richard; Haydon, Andrew; Cebon, Jonathan S 
367Dec-2016Radiation therapy staffing model 2014.Smith, Leigh J; Kearvell, Rachel; Arnold, Anthony J; Choma, Kevina; Cooper, Aniko; Young, Michael R; Matthews, Donna L; Hilder, Bronwyn; Howson, Debbie; Fox, Katherine; Churcher, Katheryn
3686-Oct-2016Immunotherapy for malignant mesothelioma: reality checkThapa, Bibhusal ; Watkins, D Neil; John, Thomas 
3699-Sep-2016Reducing cardiac doses: a novel multi-leaf collimator modification technique to reduce left anterior descending coronary artery dose in patients with left-sided breast cancerWelsh, Briana; Chao, Michael ; Foroudi, Farshad 
370Jul-2016Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization.Fahey, Frederic H; Bom, Henry Hee-Seung; Chiti, Arturo; Choi, Yun Young; Huang, Gang; Lassmann, Michael; Laurin, Norman; Mut, Fernando; Nuñez-Miller, Rodolfo; O'Keeffe, Darin; Pradhan, Prasanta; Scott, Andrew M ; Song, Shaoli; Soni, Nischal; Uchiyama, Mayuki; Vargas, Luis
37121-Jun-2016Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.Gray, H J; Benigno, B; Berek, J; Chang, J; Mason, J; Mileshkin, L; Mitchell, Paul L R ; Moradi, M; Recio, F O; Michener, C M; Secord, A Alvarez; Tchabo, N E; Chan, J K; Young, J; Kohrt, H; Gargosky, S E; Goh, J C
37210-May-2016Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.Bowyer, S; Prithviraj, Prashanth; Lorigan, P; Larkin, J; McArthur, G; Atkinson, V; Millward, M; Khou, M; Diem, S; Ramanujam, S; Kong, B; Liniker, E; Guminski, A; Parente, P; Andrews, M C; Parakh, S ; Cebon, Jonathan S ; Long, G V; Carlino, M S; Klein, O 
37311-Dec-2015A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells.Solomon, Benjamin J; Desai, Jayesh; Rosenthal, Mark; McArthur, Grant A; Pattison, Scott T; Pattison, Stacey L; MacDiarmid, Jennifer; Brahmbhatt, Himanshu; Scott, Andrew M 
374Dec-2015First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.Whittle, James R; Lickliter, Jason D; Gan, Hui K ; Scott, Andrew M ; Simes, John; Solomon, Benjamin J; MacDiarmid, Jennifer A; Brahmbhatt, Himanshu; Rosenthal, Mark A
375Nov-2015Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancerPham, Daniel; Kron, Tomas; Bressel, Mathias; Foroudi, Farshad ; Hardcastle, Nicholas; Schneider, Michal; Soteriou, Sally; Innes, Jayson; Siva, Shankar
376Oct-2015Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer.Johnstone, Cameron N ; Chand, Ashwini; Putoczki, Tracy L; Ernst, Matthias 
377Jun-2015Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.Mitchell, Paul L R ; Thatcher, N; Socinski, M A; Wasilewska-Tesluk, E; Horwood, K; Szczesna, A; Martín, C; Ragulin, Y; Zukin, M; Helwig, C; Falk, M; Butts, C; Shepherd, F A
37810-Apr-2015Pregnancy Associated Plasma Protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion.Prithviraj, Prashanth; Anaka, Matthew; McKeown, Sonja J; Permezel, Michael; Walkiewicz, Marzena; Cebon, Jonathan S ; Behren, Andreas; Jayachandran, Aparna
37917-Dec-2014Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.Woods, Katherine; Pasam, Anupama; Jayachandran, Aparna; Andrews, Miles C; Cebon, Jonathan S 
3809-Dec-2014Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.Deb, Siddhartha; Wong, S Q; Li, J ; Do, Hongdo; Weiss, J ; Byrne, D; Chakrabarti, A; Bosma, T; Fellowes, A; Dobrovic, Alexander ; Fox, S B